Pre-hospital fibrinolysis in the management of patients with ST elevation acute coronary syndrome: Review of the evidence, implementation and future directions

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 13, Issue 3, 2013, Pages 243-255

  Camuglia, A C ^a,b   Luis, S A ^a,b   Sengupta, A ^a   Bett, J H N ^a,b   Walters, D L ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acute myocardial infarction; Facilitated percutaneous coronary intervention; Pre hospital fibrinolysis; Pre hospital thrombolysis; Primary percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; HEPARIN; RETEPLASE; TENECTEPLASE; TIROFIBAN;

BLOOD CLOT LYSIS; CARDIOVASCULAR MORTALITY; ELECTROCARDIOGRAPHY; FIBRINOLYSIS; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; ISCHEMIC PRECONDITIONING; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REPERFUSION; REVIEW; SCANNING ELECTRON MICROSCOPY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION;

ACUTE CORONARY SYNDROME; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; TREATMENT OUTCOME;

EID: 84893458493     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X1303140129155809     Document Type: Review

References (94)

1. Braunwald, E. Personal reflections on fibrinolytic therapy of acute myocardial infarction. J. Thromb. Haemost., 2006, 4(3), 684-5.
2. Boersma, E. The Primary Coronary Angioplasty vs. Thrombolysis-2 Trialists' Collaborative, G., Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur. Heart J., 2006, 27(7), 779-788.
3. Stenestrand, U.; Lindback, J.; Wallentin, L.; Registry, R.-H. Longterm outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with STelevation myocardial infarction. JAMA, 2006, 296(14), 1749-56.
4. Huber, K.; De Caterina, R.; Kristensen, S. D.; Verheugt, F. W.; Montalescot, G.; Maestro, L. B.; Van de Werf, F. Task Force on Pre-hospital Reperfusion Therapy of the Working Group on Thrombosis of the, E. S. C., Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur. Heart J., 2005, 26(19), 2063-74.
5. Boersma, E.; Maas, A. C.; Deckers, J. W.; Simoons, M. L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet, 1996, 348(9030), 771-5.
6. Gersh, B. J.; Anderson, J. L. Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm-paradoxic or predictable? Circulation, 1993, 88(1), 296-306.
7. Gersh, B. J.; Stone, G. W.; White, H. D.; Holmes, D. R., Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA, 2005, 293(8), 979-86.
8. Gersh, B. J.; Antman, E. M. Selection of the optimal reperfusion strategy for STEMI: does time matter? Eur. Heart J., 2006, 27(7), 761-763.
9. Arntz, H. R. Reperfusion strategies in ST-elevation myocardial infarction-current status and perspectives for early and prehospital treatment. Resuscitation, 2008, 77(3), 296-305.
10. Newby, D. E. Triggering of acute myocardial infarction: beyond the vulnerable plaque. Heart 2010, 96(15), 1247-51.
11. Davies, M. J. The composition of coronary-artery plaques. N. Engl. J. Med., 1997, 336(18), 1312-4.
12. Puig, O.; Yuan, J.; Stepaniants, S.; Zieba, R.; Zycband, E.; Morris, M.; Coulter, S.; Yu, X.; Menke, J.; Woods, J.; Chen, F.; Ramey, D. R.; He, X.; O'Neill, E. A.; Hailman, E.; Johns, D. G.; Hubbard, B. K.; Yee Lum, P.; Wright, S. D.; DeSouza, M. M.; Plump, A.; Reiser, V. R. A Gene Expression Signature That Classifies Human Atherosclerotic Plaque by Relative Inflammation Status/Clinical Perspective. Circ. Cardiovasc. Genet., 2011, 4(6), 595-604.
13. Fuster, V.; Moreno, P. R.; Fayad, Z. A.; Corti, R.; Badimon, J. J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J. Am. Coll. Cardiol., 2005, 46(6), 937-54 (2005).
14. Silvain, J.; Collet, J. P.; Nagaswami, C.; Beygui, F.; Edmondson, K. E.; Bellemain-Appaix, A.; Cayla, G.; Pena, A.; Brugier, D.; Barthelemy, O.; Montalescot, G.; Weisel, J. W. Composition of coronary thrombus in acute myocardial infarction. J. Am. Coll. Cardiol., 57(12), 1359-67 (2011).
15. Arbab-Zadeh, A.; Nakano, M.; Virmani, R.; Fuster, V. Acute coronary events. Circulation, 125(9), 1147-56 (2012).
16. Davies, M. J. The pathophysiology of acute coronary syndromes. Heart, 2000, 83(3), 361-366.
17. Van de Werf, F.; Bax, J.; Betriu, A.; Blomstrom-Lundqvist, C.; Crea, F.; Falk, V.; Filippatos, G.; Fox, K.; Huber, K.; Kastrati, A.; Rosengren, A.; Steg, P. G.; Tubaro, M.; Verheugt, F.; Weidinger, F.; Weis, M.; Guidelines, E. S. C. C. f. P.; Vahanian, A.; Camm, J.; De Caterina, R.; Dean, V.; Dickstein, K.; Funck-Brentano, C.; Hellemans, I.; Kristensen, S. D.; McGregor, K.; Sechtem, U.; Silber, S.; Tendera, M.; Widimsky, P.; Zamorano, J. L.; Document, R.; Aguirre, F. V.; Al-Attar, N.; Alegria, E.; Andreotti, F.; Benzer, W.; Breithardt, O.; Danchin, N.; Mario, C. D.; Dudek, D.; Gulba, D.; Halvorsen, S.; Kaufmann, P.; Kornowski, R.; Lip, G. Y. H.; Rutten, F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart J., 2008, 29(23), 2909-2945.
18. Leander, K.; Blomback, M.; Wallen, H.; He, S. Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction. Thromb. Haemost., 2012, 107(6), 1092-9.
19. Thogersen, A. M.; Jansson, J. H.; Boman, K.; Nilsson, T. K.; Weinehall, L.; Huhtasaari, F.; Hallmans, G. High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor. Circulation, 1998, 98(21), 2241-2247.
20. Alessi, M. C.; Juhan-Vague, I.; Kooistra, T.; Declerck, P. J.; Collen, D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb. Haemost., 1988, 60(3), 491-4.
21. Hotamisligil, G. S.; Shargill, N. S.; Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance. Science, 1993, 259(5091), 87-91.
22. Kahn, B. B.; Flier, J. S. Obesity and insulin resistance. J. Clin. Invest., 2000, 106(4), 473-481.
23. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. The European Myocardial Infarction Project Group. N. Engl. J. Med., 1993, 329(6), 383-9.
24. Weaver, W. D.; Cerqueira, M.; Hallstrom, A. P.; Litwin, P. E.; Martin, J. S.; Kudenchuk, P. J.; Eisenberg, M. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA, 1993, 270(10), 1211-6.
25. Rawles, J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J. Am. Coll. Cardiol., 1994, 23(1), 1-5.
26. Morrison, L. J.; Verbeek, P. R.; McDonald, A. C.; Sawadsky, B. V.; Cook, D. J. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA, 2000, 283(20), 2686-92.
27. Rawles, J. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis. Heart, 2003, 89(5), 563-4.
28. Danchin, N.; Blanchard, D.; Steg, P. G.; Sauval, P.; Hanania, G.; Goldstein, P.; Cambou, J. P.; Gueret, P.; Vaur, L.; Boutalbi, Y.; Genes, N.; Lablanche, J. M.; Investigators, U. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation, 2004, 110(14), 1909-15.
29. Danchin, N.; Coste, P.; Ferrieres, J.; Steg, P. G.; Cottin, Y.; Blanchard, D.; Belle, L.; Ritz, B.; Kirkorian, G.; Angioi, M.; Sans, P.; Charbonnier, B.; Eltchaninoff, H.; Gueret, P.; Khalife, K.; Asseman, P.; Puel, J.; Goldstein, P.; Cambou, J. P.; Simon, T.; Investigators, F.-M. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute STelevation myocardial infarction (FAST-MI). Circulation, 2008, 118(3), 268-76.
30. Levine, G. N.; Bates, E. R.; Blankenship, J. C.; Bailey, S. R.; Bittl, J. A.; Cercek, B.; Chambers, C. E.; Ellis, S. G.; Guyton, R. A.; Hollenberg, S. M.; Khot, U. N.; Lange, R. A.; Mauri, L.; Mehran, R.; Moussa, I. D.; Mukherjee, D.; Nallamothu, B. K.; Ting, H. H. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary. Circulation, 2011, 124(23), 2574-2609.
31. O'Gara, P. T.; Kushner, F. G.; Ascheim, D. D.; Casey, D. E., Jr.; Chung, M. K.; de Lemos, J. A.; Ettinger, S. M.; Fang, J. C.; Fesmire, F. M.; Franklin, B. A.; Granger, C. B.; Krumholz, C. B.; Linderbaum, J. A.; Morrow, D. A.; Newby, L. K.; Ornato, J. P.; Ou, N.; Radford, M. J.; Tamis-Holland, J. E.; Tommaso, J. E.; Tracy, C. M.; Woo, Y. J.; Zhao, D. X.; Force, C. A. T. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2013, 127(4), 529-55.
32. Keeley, E. C.; Boura, J. A.; Grines, C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, 2003, 361 (9351), 13-20.
33. Fath-Ordoubadi, F.; Beatt, K. J. Fibrinolytic therapy in suspected acute myocardial infarction. Lancet, 1994, 343 (8902), 912.
34. Bonnefoy, E.; Lapostolle, F.; Leizorovicz, A.; Steg, G.; McFadden, E. P.; Dubien, P. Y.; Cattan, S.; Boullenger, E.; Machecourt, J.; Lacroute, J. M.; Cassagnes, J.; Dissait, F.; Touboul, P. Comparison of, A.; Prehospital Thromboysis in Acute Myocardial Infarction study, g., Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet, 2002, 360(9336), 825-9.
35. Bonnefoy, E.; Steg, P. G.; Boutitie, F.; Dubien, P. Y.; Lapostolle, F.; Roncalli, J.; Dissait, F.; Vanzetto, G.; Leizorowicz, A.; Kirkorian, G.; Investigators, C.; Mercier, C.; McFadden, E. P.; Touboul, P. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur. Heart J., 2009, 30 (13), 1598-606.
36. Bonnefoy, E.; Steg, P. G.; Chabaud, S.; Dubien, P.-Y.; Lapostolle, F.; Boudet, F.; Lacroute, J.-M.; Dissait, F.; Vanzetto, G.; Leizorowicz, A.; Touboul, P. Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial. Eur. Heart J., 2005, 26(17), 1712-1718.
37. Vaughan, D. E.; Lazos, S. A.; Tong, K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J. Clin. Invest., 1995, 95 (3), 995.
38. Moyer, P.; Ornato, J. P.; Brady, W. J., Jr.; Davis, L. L.; Ghaemmaghami, C. A.; Gibler, W. B.; Mears, G.; Mosesso, V. N.; Jr.; Zane, R. D. Development of systems of care for ST-elevation myocardial infarction patients: the emergency medical services and emergency department perspective. Circulation, 2007, 116 (2), e43-8.
39. Terkelsen, C. J.; Lassen, J. F.; Norgaard, B. L.; Gerdes, J. C.; Poulsen, S. H.; Bendix, K.; Ankersen, J. P.; Gotzsche, L. B.; Romer, F. K.; Nielsen, T. T.; Andersen, H. R. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of prehospital diagnosis and direct referral to primary percutanous coronary intervention. Eur. Heart J., 2005, 26(8), 770-7.
40. Brieger, D. B. Prehospital thrombolysis for STEMI: a strategy for town and country? Comment. Med. J. Aust., 2011, 195(3), 157-8.
41. Armstrong, P. W.; Committee, W. S. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur. Heart J., 2006, 27 (13), 1530-8.
42. Armstrong, P. W.; Gershlick, A. H.; Goldstein, P.; Wilcox, R.; Danays, T.; Lambert, Y.; Sulimov, V.; Ortiz, F. R.; Ostojic, M.; Welsh, R. C.; Carvalho, A. C.; Nanas, J.; Arntz, H. R.; Halvorsen, S.; Huber, K.; Grajek, S.; Fresco, C.; Bluhmki, E.; Regelin, A.; Vandenberghe, K.; Bogaerts, K.; Van de Werf, F.; the, S. I. T., Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction. N. Engl. J. Med., 2013, 368(15), 1379-87.
43. Kalla, K.; Christ, G.; Karnik, R.; Malzer, R.; Norman, G.; Prachar, H.; Schreiber, W.; Unger, G.; Glogar, H. D.; Kaff, A.; Laggner, A. N.; Maurer, G.; Mlczoch, J.; Slany, J.; Weber, H. S.; Huber, K.; Vienna, S. R. G. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation, 2006, 113(20), 2398-405.
44. Huynh, T.; Birkhead, J.; Huber, K.; O'Loughlin, J.; Stenestrand, U.; Weston, C.; Jernberg, T.; Schull, M.; Welsh, R. C.; Denktas, A. E.; Travers, A.; Sookram, S.; Theroux, P.; Tu, J. V.; Timmis, A.; Smalling, R.; Danchin, N. The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination. JACC Cardiovasc. Interv., 2011, 4(8), 877-83.
45. Smith, A. M.; Hardy, P. J.; Sandler, D. A.; Cooke, J. Paramedic decision making: prehospital thrombolysis and beyond. Emerg. Med. J., 2011, 28(8), 700-2.
46. Welsh, R. C.; Travers, A.; Senaratne, M.; Williams, R.; Armstrong, P. W. Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. Am. Heart J., 2006, 152 (6), 1007-14.
47. Castaigne, A. D.; Hervé, C.; Duval-Moulin, A.-M.; Gaillard, M.; Dubois-Rande, J.-L.; Boesch, C.; Wolf, M.; Lellouche, D.; Jan, F.; Vernant, P.; Huguenard, P. Prehospital use of APSAC: Results of a placebo-controlled study. Am. J. Cardiol., 1989, 64(2), A30-A33.
48. Schofer, J.; Buttner, J.; Geng, G.; Gutschmidt, K.; Herden, H. N.; Mathey, D. G.; Moecke, H. P.; Polster, P.; Raftopoulo, A.; Sheehan, F. H.; et al. Prehospital thrombolysis in acute myocardial infarction. Am. J. Cardiol., 1990, 66(20), 1429-33.
49. Roth, A.; Barbash, G. I.; Hod, H.; Miller, H. I.; Rath, S.; Modan, M.; Har-Zahav, Y.; Keren, G.; Bassan, S.; Kaplinsky, E. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J. Am. Coll. Cardiol., 1990, 15(5), 932-936.
50. Feldman, J. A.; Brinsfield, K.; Bernard, S.; White, D.; Maciejko, T. Real-time paramedic compared with blinded physician identification of ST-segment elevation myocardial infarction: results of an observational study. Am. J. Emerg. Med., 2005, 23(4), 443-8.
51. Foster, D. B.; Dufendach, J. H.; Barkdoll, C. M.; Mitchell, B. K. Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: Impact on in-hospital times to thrombolysis in a rural community hospital. Am. J. Emerg. Med., 1994, 12(1), 25-31.
52. Ting, H. H.; Krumholz, H. M.; Bradley, E. H.; Cone, D. C.; Curtis, J. P.; Drew, B. J.; Field, J. M.; French, W. J.; Gibler, W. B.; Goff, D. C.; Jacobs, A. K.; Nallamothu, B. K.; O'Connor, R. E.; Schuur, J. D. Implementation and Integration of Prehospital ECGs Into Systems of Care for Acute Coronary Syndrome. Circulation, 2008, 118(10), 1066-1079.
53. Whitbread, M.; Leah, V.; Bell, T.; Coats, T. J. Recognition of ST elevation by paramedics. Emerg. Med. J., 2002, 19(1), 66-7.
54. Kimura, E.; Obayashi, K.; Akazome, T.; Hayakawa, H.; Kasai, G.; Abe, Z. E.; Suzuki, T.; Kato, K. Automatic ECG and arrhythmia interpreter-an almost analog device. J. Electrocardiol., 1973, 6(2), 137-48.
55. Heden, B.; Ohlin, H.; Rittner, R.; Edenbrandt, L. Acute myocardial infarction detected in the 12-lead ECG by artificial neural networks. Circulation, 1997, 96(6), 1798-802.
56. Willems, J. L.; Abreu-Lima, C.; Arnaud, P.; van Bemmel, J. H.; Brohet, C.; Degani, R.; Denis, B.; Gehring, J.; Graham, I.; van Herpen, G.; et al. The diagnostic performance of computer programs for the interpretation of electrocardiograms. N. Engl. J. Med., 1991, 325(25), 1767-73.
57. Haraldsson, H.; Edenbrandt, L.; Ohlsson, M. Detecting acute myocardial infarction in the 12-lead ECG using Hermite expansions and neural networks. Artif. Intell. Med., 2004, 32(2), 127-36.
58. Massel, D.; Dawdy, J. A.; Melendez, L. J. Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibility. Am. Heart J., 2000, 140(2), 221-226.
59. Lamfers, E. J.; Schut, A.; Hertzberger, D. P.; Hooghoudt, T. E.; Stolwijk, P. W.; Boersma, E.; Simoons, M. L.; Verheugt, F. W. Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. Am. Heart J., 2004, 147(3), 509-15.
60. Kudenchuk, P. J.; Ho, M. T.; Weaver, W. D.; Litwin, P. E.; Martin, J. S.; Eisenberg, M. S.; Hallstrom, A. P.; Cobb, L. A.; Kennedy, J. W. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. J. Am. Coll. Cardiol., 1991, 17(7), 1486-91.
61. Dhruva, V. N.; Abdelhadi, S. I.; Anis, A.; Gluckman, W.; Hom, D.; Dougan, W.; Kaluski, E.; Haider, B.; Klapholz, M. ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction (STAT-MI) Trial. J. Am. Coll. Cardiol., 2007, j. jacc. 2007. 04. 049.
62. Sanchez-Ross, M.; Oghlakian, G.; Maher, J.; Patel, B.; Mazza, V.; Hom, D.; Dhruva, V.; Langley, D.; Palmaro, J.; Ahmed, S.; Kaluski, E.; Klapholz, M. The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) Trial Improves Outcomes. JACC Cardiovasc. Int., 2011, 4(2), 222-227.
63. Adams, G. L.; Campbell, P. T.; Adams, J. M.; Strauss, D. G.; Wall, K.; Patterson, J.; Shuping, K. B.; Maynard, C.; Young, D.; Corey, C.; Thompson, A.; Lee, B. A.; Wagner, G. S. Effectiveness of prehospital wireless transmission of electrocardiograms to a cardiologist via hand-held device for patients with acute myocardial infarction (from the Timely Intervention in Myocardial Emergency, NorthEast Experience [TIME-NE]). Am. J. Cardiol., 2006, 98(9), 1160-4.
64. Gershlick, A. H.; Stephens-Lloyd, A.; Hughes, S.; Abrams, K. R.; Stevens, S. E.; Uren, N. G.; de Belder, A.; Davis, J.; Pitt, M.; Banning, A.; Baumbach, A.; Shiu, M. F.; Schofield, P.; Dawkins, K. D.; Henderson, R. A.; Oldroyd, K. G.; Wilcox, R.; Investigators, R. T. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med., 2005, 353(26), 2758-68.
65. Saia, F.; Marrozzini, C.; Ortolani, P.; Palmerini, T.; Guastaroba, P.; Cortesi, P.; Pavesi, P. C.; Gordini, G.; Pancaldi, L. G.; Taglieri, N.; di Pasquale, G.; Branzi, A.; Marzocchi, A., Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart 2009, 95(5), 370-6.
66. Saia, F.; Marrozzini, C.; Guastaroba, P.; Ortolani, P.; Palmerini, T.; Pavesi, P. C.; Gordini, G.; Pancaldi, L. G.; Taglieri, N.; Palma, R.; Pasquale, G.; Branzi, A.; Marzocchi, A. Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. Acute Card. Care, 2010, 12(2), 42-50.
67. Borgia, F.; Goodman, S. G.; Halvorsen, S.; Cantor, W. J.; Piscione, F.; Le May, M. R.; Fernandez-Aviles, F.; Sanchez, P. L.; Dimopoulos, K.; Scheller, B.; Armstrong, P. W.; Di Mario, C. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur. Heart J., 2010, 31(17), 2156-69.
68. Di Mario, C.; Dudek, D.; Piscione, F.; Mielecki, W.; Savonitto, S.; Murena, E.; Dimopoulos, K.; Manari, A.; Gaspardone, A.; Ochala, A.; Zmudka, K.; Bolognese, L.; Steg, P. G.; Flather, M.; Investigators, C.-i.-A. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet, 2008, 371(9612), 559-68.
69. Bohmer, E.; Hoffmann, P.; Abdelnoor, M.; Arnesen, H.; Halvorsen, S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J. Am. Coll. Cardiol., 2010, 55(2), 102-10.
70. Cantor, W. J.; Fitchett, D.; Borgundvaag, B.; Ducas, J.; Heffernan, M.; Cohen, E. A.; Morrison, L. J.; Langer, A.; Dzavik, V.; Mehta, S. R.; Lazzam, C.; Schwartz, B.; Casanova, A.; Goodman, S. G.; Investigators, T.-A. T. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N. Engl. J. Med., 2009, 360(26), 2705-18.
71. Horne, S.; Weston, C.; Quinn, T.; Hicks, A.; Walker, L.; Chen, R.; Birkhead, J. The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart, 2009, 95(7), 559-63.
72. DeCarolis, D, S. P.; Eikelboom, J.; Bassand, J. Correspondance: Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction. N. Engl. J. Med., 2006, 354(26), 2830-2832.
73. Antman, E. M.; Morrow, D. A.; McCabe, C. H.; Murphy, S. A.; Ruda, M.; Sadowski, Z.; Budaj, A.; Lopez-Sendon, J. L.; Guneri, S.; Jiang, F.; White, H. D.; Fox, K. A.; Braunwald, E.; Ex, T.-T. I. Enoxaparin versus unfractionated heparin with fibrinolysis for STelevation myocardial infarction. N. Engl. J. Med., 2006, 354(14), 1477-88.
74. Morrow, D. A.; Antman, E. M.; Fox, K. A. A.; White, H. D.; Giugliano, R.; Murphy, S. A.; McCabe, C. H.; Braunwald, E. Oneyear outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACTTIMI 25 Trial. Eur. Heart J., 2010, 31(17), 2097-2102.
75. Wallentin, L.; Goldstein, P.; Armstrong, P. W.; Granger, C. B.; Adgey, A. A.; Arntz, H. R.; Bogaerts, K.; Danays, T.; Lindahl, B.; Makijarvi, M.; Verheugt, F.; Van de Werf, F. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation, 2003, 108(2), 135-42.
76. Verheugt, F. W.; Montalescot, G.; Sabatine, M. S.; Soulat, L.; Lambert, Y.; Lapostolle, F.; Adgey, J.; Cannon, C. P. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial. J. Thromb. Thrombolysis, 2007, 23(3), 173-9.
77. Montalescot, G.; Wiviott, S. D.; Braunwald, E.; Murphy, S. A.; Gibson, C. M.; McCabe, C. H.; Antman, E. M.; investigators, T.-T. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet, 2009, 373(9665), 723-31.
78. Cannon, C. P.; Harrington, R. A.; James, S.; Ardissino, D.; Becker, R. C.; Emanuelsson, H.; Husted, S.; Katus, H.; Keltai, M.; Khurmi, N. S.; Kontny, F.; Lewis, B. S.; Steg, P. G.; Storey, R. F.; Wojdyla, D.; Wallentin, L.; inhibition, P. L.; patient Outcomes, I. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet, 2010, 375(9711), 283-93.
79. Tubaro, M.; Danchin, N.; Goldstein, P.; Filippatos, G.; Hasin, Y.; Heras, M.; Jansky, P.; Norekval, T. M.; Swahn, E.; Thygesen, K.; Vrints, C.; Zahger, D.; Arntz, H. R.; Bellou, A.; De La Coussaye, J. E.; De Luca, L.; Huber, K.; Lambert, Y.; Lettino, M.; Lindahl, B.; McLean, S.; Nibbe, L.; Peacock, W. F.; Price, S.; Quinn, T.; Spaulding, C.; Tatu-Chitoiu, G.; Van De Werf, F. Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology. Acute Card. Care, 2011, 13(2), 56-67.
80. Ross, A. M.; Coyne, K. S.; Reiner, J. S.; Greenhouse, S. W.; Fink, C.; Frey, A.; Moreyra, E.; Traboulsi, M.; Racine, N.; Riba, A. L.; Thompson, M. A.; Rohrbeck, S.; Lundergan, C. F. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J. Am. Coll. Cardiol., 1999, 34(7), 1954-62.
81. Kastrati, A.; Mehilli, J.; Schlotterbeck, K.; Dotzer, F.; Dirschinger, J.; Schmitt, C.; Nekolla, S. G.; Seyfarth, M.; Martinoff, S.; Markwardt, C.; Clermont, G.; Gerbig, H. W.; Leiss, J.; Schwaiger, M.; Schomig, A. Bavarian Reperfusion Alternatives Evaluation Study, I., Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA, 2004, 291(8), 947-54.
82. Le May, M. R.; Wells, G. A.; Labinaz, M.; Davies, R. F.; Turek, M.; Leddy, D.; Maloney, J.; McKibbin, T.; Quinn, B.; Beanlands, R. S.; Glover, C.; Marquis, J. F.; O'Brien, E. R.; Williams, W. L.; Higginson, L. A. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J. Am. Coll. Cardiol., 2005, 46(3), 417-24.
83. Collet, J. P.; Montalescot, G.; Le May, M.; Borentain, M.; Gershlick, A. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J. Am. Coll. Cardiol., 2006, 48(7), 1326-35.
84. Keeley, E. C.; Boura, J. A.; Grines, C. L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet, 2006, 367(9510), 579-88.
85. Assessment of the, S.; Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention, i., Primary versus tenecteplasefacilitated percutaneous coronary intervention in patients with STsegment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet, 2006, 367(9510), 569-78.
86. Ellis, S. G.; Tendera, M.; de Belder, M. A.; van Boven, A. J.; Widimsky, P.; Janssens, L.; Andersen, H. R.; Betriu, A.; Savonitto, S.; Adamus, J.; Peruga, J. Z.; Kosmider, M.; Katz, O.; Neunteufl, T.; Jorgova, J.; Dorobantu, M.; Grinfeld, L.; Armstrong, P.; Brodie, B. R.; Herrmann, H. C.; Montalescot, G.; Neumann, F. J.; Effron, M. B.; Barnathan, E. S.; Topol, E. J.; Investigators, F., Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med., 2008, 358(21), 2205-17.
87. Thiele, H.; Eitel, I.; Meinberg, C.; Desch, S.; Leuschner, A.; Pfeiffer, D.; Hartmann, A.; Lotze, U.; Strauss, W.; Schuler, G.; Group, L.-S. T. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc. Interv., 2011, 4(6), 605-14.
88. Larson, D. M.; Duval, S.; Sharkey, S. W.; Garberich, R. F.; Madison, J. D.; Stokman, P. J.; Dirks, T. G.; Westin, R. K.; Harris, J. L.; Henry, T. D. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur. Heart J., 2012, 33, 1232-1240.
89. Lee, D. P.; Herity, N. A.; Hiatt, B. L.; Fearon, W. F.; Rezaee, M.; Carter, A. J.; Huston, M.; Schreiber, D.; DiBattiste, P. M.; Yeung, A. C. Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes. Circulation, 2003, 107(11), 1497-1501.
90. Gyongyosi, M.; Domanovits, H.; Benzer, W.; Haugk, M.; Heinisch, B.; Sodeck, G.; Hodl, R.; Gaul, G.; Bonner, G.; Wojta, J.; Laggner, A.; Glogar, D.; Huber, K.; ReoPro, B. S. G. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion-results of the Austrian multi-centre randomized ReoPro-BRIDGING Study. Eur. Heart J., 2004, 25(23), 2125-33.
91. Zeymer, U.; Zahn, R.; Schiele, R.; Jansen, W.; Girth, E.; Gitt, A.; Seidl, K.; Schryder, R.; Schneider, S.; Senges, J. Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial. Eur. Heart J., 2005, 26(19), 1971-1977.
92. Wijns, W.; Kolh, P.; Danchin, N.; Di Mario, C.; Falk, V.; Folliguet, T.; Garg, S.; Huber, K.; James, S.; Knuuti, J.; Lopez-Sendon, J.; Marco, J.; Menicanti, L.; Ostojic, M.; Piepoli, M. F.; Pirlet, C.; Pomar, J. L.; Reifart, N.; Ribichini, F. L.; Schalij, M. J.; Sergeant, P.; Serruys, P. W.; Silber, S.; Sousa Uva, M.; Taggart, D. Guidelines on myocardial revascularization. Eur. Heart J., 2010, 31(20), 2501-55.
93. O'Connor, R. E.; Bossaert, L.; Arntz, H.-R.; Brooks, S. C.; Diercks, D.; Feitosa-Filho, G.; Nolan, J. P.; Hoek, T. L. V.; Walters, D. L.; Wong, A.; Welsford, M.; Woolfrey, K. Part 9: Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation, 2010, 122(16Suppl 2), S422-S465.
94. Lambert, L.; Brown, K.; Segal, E.; Brophy, J.; Rodes-Cabau, J.; Bogaty, P. Association Between Timeliness of Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial Infarction. JAMA, 2010, 303(21), 2148-2155.